Brian Shoichet is the new director of the QB3 at UCSF
Tuesday, April 3, 2012
Computational chemist Brian Shoichet, PhD, a faculty member in the Department of Pharmaceutical Chemistry, UCSF School of Pharmacy, is the new director of the California Institute for Quantitative Biosciences (QB3) at UCSF.
QB3, with research facilities at UC campuses in San Francisco, Berkeley, and Santa Cruz, has an academic director at each site, as well as a director who oversees operations as a whole.
As director of QB3-UCSF, Shoichet will control a $1.5 million annual budget that supports core research staff and facilities in Byers Hall and Genentech Hall on the UCSF Mission Bay campus. He will also serve on the QB3 Executive Committee.
“What I’m most excited by is that I buy into Brian’s vision of systems pharmacology,” says Regis Kelly, PhD, director of QB3 overall. “He brings together people working in a range of fields, from pharmacokinetics to protein-protein interactions, to see if we can overcome major problems facing the pharmaceutical industry.”
The institute aligns scientists and facilities for research in the quantitative biosciences, which uses the tools of physics, chemistry, and computer science to address biological questions.
The institute also seeks to bring new treatments, tools, and solutions to market via collaboration with industry and support for start-ups via incubator lab facilities. The latter effort includes mentoring, legal, and financial connections for bio-entrepreneurs.
Shoichet follows Andrej Sali, PhD, as QB3’s director at UCSF. Sali, who is a faculty member in Department of Bioengineering and Therapeutic Sciences, a joint department of the UCSF Schools of Pharmacy and Medicine, led the campus program since 2009.
Go to: UCSF School of Pharmacy News